These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18384376)

  • 41. Regulation of translation factors eIF4GI and 4E-BP1 during recovery of protein synthesis from inhibition by p53.
    Constantinou C; Clemens MJ
    Cell Death Differ; 2007 Mar; 14(3):576-85. PubMed ID: 16990847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential p70S6k and 4E-BP1 regulation by insulin and amino acids in vascular endothelial and smooth muscle cells.
    Terruzzi I; Pellegatta F; Luzi L
    Acta Diabetol; 2005 Oct; 42(3):139-46. PubMed ID: 16258737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.
    Mishra R; Miyamoto M; Yoshioka T; Ishikawa K; Matsumura Y; Shoji Y; Ichinokawa K; Itoh T; Shichinohe T; Hirano S; Kondo S
    Int J Oncol; 2009 May; 34(5):1231-40. PubMed ID: 19360336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P; Mateo J
    Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma.
    Seki N; Takasu T; Sawada S; Nakata M; Nishimura R; Segawa Y; Shibakuki R; Hanafusa T; Eguchi K
    Lung Cancer; 2010 Dec; 70(3):329-34. PubMed ID: 20621385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.
    Graff JR; Konicek BW; Lynch RL; Dumstorf CA; Dowless MS; McNulty AM; Parsons SH; Brail LH; Colligan BM; Koop JW; Hurst BM; Deddens JA; Neubauer BL; Stancato LF; Carter HW; Douglass LE; Carter JH
    Cancer Res; 2009 May; 69(9):3866-73. PubMed ID: 19383915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Raptor, a binding partner of target of rapamycin.
    Yonezawa K; Tokunaga C; Oshiro N; Yoshino K
    Biochem Biophys Res Commun; 2004 Jan; 313(2):437-41. PubMed ID: 14684181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Redox-regulated affinity of the third PDZ domain in the phosphotyrosine phosphatase PTP-BL for cysteine-containing target peptides.
    van den Berk LC; Landi E; Harmsen E; Dente L; Hendriks WJ
    FEBS J; 2005 Jul; 272(13):3306-16. PubMed ID: 15978037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structures of the human eIF4E homologous protein, h4EHP, in its m7GTP-bound and unliganded forms.
    Rosettani P; Knapp S; Vismara MG; Rusconi L; Cameron AD
    J Mol Biol; 2007 May; 368(3):691-705. PubMed ID: 17368478
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissociation of the eukaryotic initiation factor-4E/4E-BP1 complex involves phosphorylation of 4E-BP1 by an mTOR-associated kinase.
    Heesom KJ; Denton RM
    FEBS Lett; 1999 Sep; 457(3):489-93. PubMed ID: 10471835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The N-terminal lysine residue-rich domain II and the 340-430 amino acid segment of eukaryotic initiation factor 2-associated glycoprotein p67 are the binding sites for the gamma-subunit of eIF2.
    Ghosh A; Datta R; Majumdar A; Bhattacharya M; Datta B
    Exp Cell Res; 2006 Oct; 312(16):3184-203. PubMed ID: 16857189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate.
    Eley HL; Russell ST; Tisdale MJ
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1409-16. PubMed ID: 18854427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
    Bibollet-Bahena O; Almazan G
    J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells.
    Avdulov S; Li S; Michalek V; Burrichter D; Peterson M; Perlman DM; Manivel JC; Sonenberg N; Yee D; Bitterman PB; Polunovsky VA
    Cancer Cell; 2004 Jun; 5(6):553-63. PubMed ID: 15193258
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polyamines regulate eukaryotic initiation factor 4E-binding protein 1 gene transcription.
    Stephenson AH; Christian JF; Seidel ER
    Biochem Biophys Res Commun; 2004 Oct; 323(1):204-12. PubMed ID: 15351722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Local control of a disorder-order transition in 4E-BP1 underpins regulation of translation via eIF4E.
    Tait S; Dutta K; Cowburn D; Warwicker J; Doig AJ; McCarthy JE
    Proc Natl Acad Sci U S A; 2010 Oct; 107(41):17627-32. PubMed ID: 20880835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinct structural features of caprin-1 mediate its interaction with G3BP-1 and its induction of phosphorylation of eukaryotic translation initiation factor 2alpha, entry to cytoplasmic stress granules, and selective interaction with a subset of mRNAs.
    Solomon S; Xu Y; Wang B; David MD; Schubert P; Kennedy D; Schrader JW
    Mol Cell Biol; 2007 Mar; 27(6):2324-42. PubMed ID: 17210633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monitoring mammalian target of rapamycin (mTOR) activity.
    Ikenoue T; Hong S; Inoki K
    Methods Enzymol; 2009; 452():165-80. PubMed ID: 19200882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
    Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
    Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. mTORC1 induces eukaryotic translation initiation factor 4E interaction with TOS-S6 kinase 1 and its activation.
    Majeed ST; Batool A; Majeed R; Bhat NN; Zargar MA; Andrabi KI
    Cell Cycle; 2021 May; 20(9):839-854. PubMed ID: 33938392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.